These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

150 related items for PubMed ID: 15470711

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Metronomic oral low-dose treosulfan chemotherapy combined with cyclooxygenase-2 inhibitor in pretreated advanced melanoma: a pilot study.
    Spieth K, Kaufmann R, Gille J.
    Cancer Chemother Pharmacol; 2003 Nov; 52(5):377-82. PubMed ID: 12879280
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Bleomycin, vinorelbine and trofosfamide in relapsed stage IV cutaneous malignant melanoma patients.
    Atzpodien J, Morawek L, Fluck M, Reitz M.
    Cancer Chemother Pharmacol; 2009 Oct; 64(5):901-5. PubMed ID: 19229537
    [Abstract] [Full Text] [Related]

  • 8. Ifosfamide/liposomal daunorubicin is a well tolerated and active first-line chemotherapy regimen in advanced soft tissue sarcoma: results of a phase II study.
    Siehl JM, Thiel E, Schmittel A, Hütter G, Deckert PM, Szelényi H, Keilholz U.
    Cancer; 2005 Aug 01; 104(3):611-7. PubMed ID: 15968689
    [Abstract] [Full Text] [Related]

  • 9. Isolated limb perfusion with melphalan and tumor necrosis factor alpha for advanced melanoma and soft-tissue sarcoma.
    Hayes AJ, Neuhaus SJ, Clark MA, Thomas JM.
    Ann Surg Oncol; 2007 Jan 01; 14(1):230-8. PubMed ID: 17066234
    [Abstract] [Full Text] [Related]

  • 10. Double-blind randomized phase II study of the combination of sorafenib and dacarbazine in patients with advanced melanoma: a report from the 11715 Study Group.
    McDermott DF, Sosman JA, Gonzalez R, Hodi FS, Linette GP, Richards J, Jakub JW, Beeram M, Tarantolo S, Agarwala S, Frenette G, Puzanov I, Cranmer L, Lewis K, Kirkwood J, White JM, Xia C, Patel K, Hersh E.
    J Clin Oncol; 2008 May 01; 26(13):2178-85. PubMed ID: 18445842
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Trofosfamide in patients with pancreatic cancer.
    Schmidt-Sandte W, Dageförde J, Klapdor R, Wagner T, Wiedemann GJ.
    Anticancer Res; 1999 May 01; 19(4A):2485-7. PubMed ID: 10470179
    [Abstract] [Full Text] [Related]

  • 14. Systemic treatment options for patients with refractory adult-type sarcoma beyond anthracyclines.
    Hartmann JT.
    Anticancer Drugs; 2007 Mar 01; 18(3):245-54. PubMed ID: 17264755
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. A new therapeutic approach in patients with advanced sarcoma.
    Kasper B, Ho AD, Egerer G.
    Int J Clin Oncol; 2005 Dec 01; 10(6):438-40. PubMed ID: 16369750
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.